Strides Shasun has received an approval for the Scheme of Amalgamation for the merger of its wholly owned subsidiaries (WOSs) viz., Arrow Remedies, Fagris Medica and Strides Chemicals, with itself. The Board of Directors of the company at their meeting held on October 31, 2017, considered and approved the same.
The merger is expected to generate synergic benefits, greater efficiency in business management, reduce duplication of statutory and regulatory compliances and eliminate duplication of operating and administrative expenses.
Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.
